Glenmark obtains FDA OK for generic MetroGel-Vaginal gel
MetroGel-Vaginal gel had a market value of approximately $60.4 million for the 12-month period ending November 2021, according to IQVIA.
The Food and Drug Administration recently approved Glenmark’s Metronidazole Vaginal gel 0.75%.
[Read more: Glenmark obtains FDA nod for generic Brovana]
The medication is the generic of Bausch Health’s MetroGel-Vaginal gel.
It is used used to treat the symptoms of bacterial vaginosis.
[Read more Glenmark Specialty S.A. receives FDA green light for Ryaltis]
MetroGel-Vaginal gel had a market value of approximately $60.4 million for the 12-month period ending November 2021, according to IQVIA.